-+ 0.00%
-+ 0.00%
-+ 0.00%

GYRE THERAPEUTICS ANNOUNCES FIRST DOSING IN PHASE 1 TRIAL OF F230 FOR PULMONARY ARTERIAL HYPERTENSION IN CHINA

Reuters·06/10/2025 11:00:00

Please log in to view news